ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2689

Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity Are Multifactorial in Early Rheumatoid Arthritis

Cécile Gaujoux-Viala1, Nathalie Rincheval2, Laure Gossec3, Francis Guillemin4, Maxime Dougados5, Jean-Pierre Daures6 and BG Combe7, 1Nîmes University Hospital, Rheumatology Department; EA 2415, Montpellier University, Nîmes, France, 2Biostatistic, EA 2415, Epidemiology unit, Montpellier, France, 3Rheumatology, Pitié Salpetriere Hospital, Paris, France, 4University of Lorraine, Nancy, France, 5Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP. INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France, 6Biostatistic, EA 2415 Epidemiology unit, Montpellier, France, 7Lapeyronie, Montpellier, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: activity score and patient outcomes, Early Rheumatoid Arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

 

 

Background/Purpose:

Patients and physicians often differ in their
perceptions of rheumatoid arthritis (RA) disease activity, as quantified by the
patient’s global assessment (PGA) and by the evaluator’s global assessment
(EGA).

The aim of this study was to explore the
extent and reasons for this discordance.

 

Methods:

-Patients: from the French cohort of early
arthritis ESPOIR (at least 2 swollen joints for less than 6 months, DMARD
naïve), fulfilling the ACR-EULAR criteria for RA at baseline

-Analyses: At baseline, agreement between
PGA and EGA (Bland-Altman plot) was assessed. Multivariate linear regression
was used to analyze data to determine the patient and early arthritis features
independently associated with discordance (calculated as PGA – EGA). Logistic
regression was used to analyze discordance as
│PGA – EGA│≥20.

 

Results:

In 645 patients with early RA (mean
age=48.8±12.2 years, 77% female, 48.7% ACPA +) agreement was better at both ends of the spectrum of the disease activity perception,
especially for patients with high disease
activity. The direction of the discrepancy usually points toward a higher
rating by the patients than by physicians themselves.

In multivariate linear regression
center-adjusted, higher PGA has been found to be associated with absence of fulfilling
ACR 1987 revised criteria for RA (p=0.0005), higher level of fatigue
(p<0.0001) and lower number of swollen joint counts (SJC) (p=0.0022). With logistic
regression center-adjusted, low number of SJC (OR 95%CI=0.522 [0.343-0.794]), low
mental component of the SF-36
(OR 95%CI=0.550 [0.371-0.815]) and living alone (OR95%CI=0.595 [0.388-0.914]) were
associated with discordance between PGA and EGA.

 

Conclusion:

In early RA, the discordance between PGA
and EGA is multifactorial with objective measures like low SJC and absence of fulfilling
ACR 1987 revised criteria for RA, but also patient reported outcomes like high
level of fatigue and low mental status, and environmental factor: living alone.
Understanding the reasons for a discordant view of disease activity will help
to facilitate the sharing of decision-making in the management of RA. In addition,
our findings represent a call to treat fatigue and anxiety-depression, as this
may create better consensus about the course of treatment.


Disclosure: C. Gaujoux-Viala, None; N. Rincheval, None; L. Gossec, None; F. Guillemin, None; M. Dougados, None; J. P. Daures, None; B. Combe, Pfizer, Roche-Chugai, 2,BMS, Merck, Pfizer, Roche-Chugai, UCB, 8.

To cite this abstract in AMA style:

Gaujoux-Viala C, Rincheval N, Gossec L, Guillemin F, Dougados M, Daures JP, Combe B. Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity Are Multifactorial in Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/discrepancies-between-patients-and-physicians-in-their-perceptions-of-rheumatoid-arthritis-disease-activity-are-multifactorial-in-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discrepancies-between-patients-and-physicians-in-their-perceptions-of-rheumatoid-arthritis-disease-activity-are-multifactorial-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology